Stroke treatment outcomes in hospitals with and without stroke units
Jaime Masjuán(Universidad de Alcalá), I.M. Navarro Soler(Universitat de Miguel Hernández d'Elx), Emilio Ignacio García(Universidad de Cádiz), M Bestué(Hospital General San Jorge), D. Vidal de Francisco(Complejo Hospitalario de Jaén), Andrés Ortiz, Jaime Gállego Culleré, Oswaldo Alberti(Hospital General San Jorge), F. Acebrón(Hospital Universitario Ramón y Cajal), Luis López-Mesonero(Hospital Virgen de la Concha)
Cited by 9
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
|The Lancet|2012|280
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
|Journal of Clinical Investigation|2005|257